For instance, IDH mutation, a critical diagnostic and prognostic marker for glioma would lead to abnormal tricarboxylic acid (TCA) cycle (Yan et al., 2009; Pirozzi and Yan, 2021). The gene discussed is IDH1; the disease is central nervous system cancer.